A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain ...

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

A major Cochrane review found no convincing evidence that ketamine or similar NMDA-blocking drugs improve chronic non-cancer ...

Who is the ketamine queen that sold fatal drug, causing Matthew Perry death? Here's what to know about ketamine and why ...

How do you send drugs to specific parts of the body so they do their job and avoid causing side effects elsewhere? According ...

Researchers show in rats that ultrasound-guided nanoparticles can deliver ketamine to specific regions of the brain and ...

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, reported financial results for the quarter ended June 30, 2025, and provided a corporate update. The Company highlighted ...

When medicines go to the wrong places in the body, the results can be rough. Antidepressants may cause feelings of detachment ...

In a groundbreaking development, researchers at Stanford University are designing a non-invasive drug delivery system that uses ultrasound and sugar-stabilised nanoparticles to target specific areas ...

More than half of patients prescribed medical cannabis for chronic musculoskeletal pain stop using it within a year, ...